Compares dialysis methods, including remote-monitored home dialysis, in people with end-stage renal disease
Compares peritoneal dialysis and hemodialysis in adults with end-stage renal disease starting dialysis.
Plain-language title generated from the registry record
Registry title: Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities
Key facts
- Where
- Baotou, Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hangzhou, Harbin, Qingdao, Shanghai, Shijiazhuang, Tianjin, Wuhan, Wuxi, Xi’an, Yantai, and Zhengzhou, ChinaSee the 20 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 79 years old?
Source: NCT07781124, who can take part
Where in China
- The First Affiliated Hospital of Baotou Medical CollegeBaotou, ChinaNot yet recruiting
- Beijing Haidian HospitalBeijing, ChinaNot yet recruiting
- China-Japan Friendship HospitalBeijing, ChinaTaking people
- Peking University First HospitalBeijing, ChinaNot yet recruiting
- Peking University Third HospitalBeijing, ChinaNot yet recruiting
- The Second Norman Bethune Hospital of Jilin UniversityChangchun, ChinaNot yet recruiting
- The Third Xiangya Hospital of Central South UniversityChangsha, ChinaNot yet recruiting
- The Second Affiliated Hospital of Chongqing Medical UniversityChongqing, ChinaNot yet recruiting
- Guangdong Provincial Hospital of Traditional Chinese MedicineGuangzhou, ChinaNot yet recruiting
- Hangzhou Hospital of Traditional Chinese MedicineHangzhou, ChinaNot yet recruiting
- The Second Affiliated Hospital of Harbin Medical UniversityHarbin, ChinaNot yet recruiting
- The Affiliated Hospital of Qingdao UniversityQingdao, ChinaNot yet recruiting
- Shanghai Sixth People's HospitalShanghai, ChinaNot yet recruiting
- Hebei medical university third hospitalShijiazhuang, ChinaNot yet recruiting
- Tianjin First Central HospitalTianjin, ChinaNot yet recruiting
- Zhongnan Hospital of Wuhan UniversityWuhan, ChinaNot yet recruiting
- Wuxi People's HospitalWuxi, ChinaNot yet recruiting
- The First Affiliated Hospital of Xi'an Jiaotong UniversityXi’an, ChinaNot yet recruiting
- Yantai Yuhuangding HospitalYantai, ChinaNot yet recruiting
- Henan Provincial People's HospitalZhengzhou, ChinaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Vantive Health LLC
- Trial code
- NCT07781124
- Record updated
- 24 August 2026
- Original description
This is a multicenter, prospective, observational real-world study designed to evaluate clinical effectiveness, quality of life, and healthcare resource utilization in patients with end-stage renal disease (ESRD) initiating dialysis therapy in China.Read full original descriptionShow less
Clinical Effectiveness and Healthcare Resource Utilization in Patients With End-Stage Renal Disease Receiving Remote Patient Monitoring-Automated Peritoneal Dialysis, Manual Peritoneal Dialysis, or Hemodialysis: A Multicenter, Prospective, Observational Real-World Study
This is a multicenter, prospective, observational real-world study designed to evaluate clinical effectiveness, quality of life, and healthcare resource utilization in patients with end-stage renal disease (ESRD) initiating dialysis therapy in China.
Participants will be grouped according to the dialysis modality selected through routine clinical practice and shared decision-making with their treating physicians: remote patient monitoring-assisted automated peritoneal dialysis (RPM-APD), manual peritoneal dialysis (PD), or maintenance hemodialysis (HD). No study-specific interventions will be assigned.
The study will compare outcomes across these cohorts, including quality of life, social reintegration, clinical outcomes (e.g., complications and survival), and healthcare resource utilization. Propensity score matching will be applied to adjust for baseline differences between cohorts.
Inclusion: Aged ≥ 18 years and < 80 years; Diagnosed with ESRD and planned to initiate RPM-APD / manual PD / HD as maintenance dialysis within 3 months after signing the ICF; Able to continue long-term follow-up and treatment at the study site after enrollment; Voluntarily sign the ICF and are able to complete study visits and questionnaires as required by the Investigator or have a caregiver to assist in completing study-related procedures.
Exclusion: Received dialysis therapy for more than 1 month; Currently participating in another interventional study or having participated in another interventional study within 1 month prior to enrollment; History of kidney transplantation; Presence of other severe diseases, such as malignancies with active or residual lesions despite treatment, systemic infections, decompensated liver cirrhosis, severe lactic acidosis, etc; Patients with HIV infection or syphilis infection; Presence of psychiatric disorders or inability to cooperate; Any other condition that, in the opinion of the Investigator, makes the patient unsuitable for participation in the study; Diagnosed with acute kidney injury (AKI); Pregnant or breastfeeding women, as well as women of childbearing potential unwilling to use effective contraception during the study period.